Related references
Note: Only part of the references are listed.CCR5 or CXCR4 use influences the relationship between CD4 cell depletion, NKp44L expression and NK cytotoxicity in SHIV-infected macaques
Vincent Vieillard et al.
AIDS (2008)
The failed HIV Merck vaccine study: A step back or a launching point for future vaccine development?
Rafick-Pierre Sekaly
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates
Thomas W. Geisbert et al.
JOURNAL OF VIROLOGY (2008)
Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and G gene truncation reduces neurovirulence and enhances immunogenicity in mice
David Cooper et al.
JOURNAL OF VIROLOGY (2008)
Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge
Kelly L. Warfield et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Ebola hemorrhagic fever: Evaluation of passive immunotherapy in nonhuman primates
Peter B. Jahrling et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever
Steven M. Jones et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus
Thomas Larsen et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
HIV-1 prophylactic vaccine comprised of topical DermaVir prime and protein boost elicits cellular immune responses and controls pathogenic R5 SHIV162P3
Anthony D. Cristillo et al.
VIROLOGY (2007)
Successful topical respiratory tract immunization of primates against ebola virus
Alexander Bukreyev et al.
JOURNAL OF VIROLOGY (2007)
Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates
J. Erik Johnson et al.
VIROLOGY (2007)
Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys
Wendelien B. Oswald et al.
PLOS PATHOGENS (2007)
Effective post-exposure treatment of Ebola infection
Heinz Feldmann et al.
PLOS PATHOGENS (2007)
Implication of a retrovirus-like glycoprotein peptide in the immunopathogenesis of Ebola and Marburg viruses
Kavitha Yaddanapudi et al.
FASEB JOURNAL (2006)
Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine
Kathleen M. Daddario-DiCaprio et al.
JOURNAL OF VIROLOGY (2006)
Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs
Nancy J. Sullivan et al.
PLOS MEDICINE (2006)
Recombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+ Th1 immune responses and are protective in mouse and guinea pig models of vaginal challenge
RJ Natuk et al.
JOURNAL OF VIROLOGY (2006)
Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates:: an efficacy assessment
KM Daddario-DiCaprio et al.
LANCET (2006)
Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine
SU Kapadia et al.
VIROLOGY (2005)
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses
SM Jones et al.
NATURE MEDICINE (2005)
Development of a new vaccine for the prevention of lassa fever
TW Geisbert et al.
PLOS MEDICINE (2005)
Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses
M Garbutt et al.
JOURNAL OF VIROLOGY (2004)
Immunogenicity of attenuated vesicular stomatitis virus vectors expressing HIV type 1 env and SIV Gag proteins: Comparison of intranasal and intramuscular vaccination routes
MA Egan et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2004)
Exotic emerging viral diseases: progress and challenges
TW Geisbert et al.
NATURE MEDICINE (2004)
Vaccination in humans generates broad T cell cytokine responses
SC De Rosa et al.
JOURNAL OF IMMUNOLOGY (2004)
Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques - Evidence that dendritic cells are early and sustained targets of infection
TW Geisbert et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates
NJ Sullivan et al.
NATURE (2003)
Vesicular stomatitis virus glycoprotein is a determinant of pathogenesis in swine, a natural host
I Martinez et al.
JOURNAL OF VIROLOGY (2003)
The cell-rounding activity of the vesicular stomatitis virus matrix protein is due to the induction of cell death
SA Kopecky et al.
JOURNAL OF VIROLOGY (2003)
Induction of immune responses in mice and monkeys to ebola virus after immunization with liposome-encapsulated irradiated ebola virus:: Protection in mice requires CD4+ T cells
M Rao et al.
JOURNAL OF VIROLOGY (2002)
Hemorrhagic fever viruses as biological weapons - Medical and public health management
L Borio et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Matrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus
SA Kopecky et al.
JOURNAL OF VIROLOGY (2001)
Replication-competent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge
JS Kahn et al.
JOURNAL OF VIROLOGY (2001)
An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants
NF Rose et al.
CELL (2001)
Development of a preventive vaccine for Ebola virus infection in primates
NJ Sullivan et al.
NATURE (2000)
Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies
B Schlereth et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
